Effects of CAG repeat length, HTT protein length and protein context on cerebral metabolism measured using magnetic resonance spectroscopy in transgenic mouse models of Huntington's disease
Open Access
- 12 September 2005
- journal article
- Published by Wiley in Journal of Neurochemistry
- Vol. 95 (2), 553-562
- https://doi.org/10.1111/j.1471-4159.2005.03411.x
Abstract
Huntington's disease is a neurodegenerative illness caused by expansion of CAG repeats at the N‐terminal end of the protein huntingtin. We examined longitudinal changes in brain metabolite levels using in vivo magnetic resonance spectroscopy in five different mouse models. There was a large (>50%) exponential decrease in N‐acetyl aspartate (NAA) with time in both striatum and cortex in mice with 150 CAG repeats (R6/2 strain). There was a linear decrease restricted to striatum in N171‐82Q mice with 82 CAG repeats. Both the exponential and linear decreases of NAA were paralleled in time by decreases in neuronal area measured histologically. Yeast artificial chromosome transgenic mice with 72 CAG repeats, but low expression levels, had less striatal NAA loss than the N171–82Q mice (15% vs. 43%). We evaluated the effect of gene context in mice with an approximate 146 CAG repeat on the hypoxanthine phosphoribosyltransferase gene (HPRT). HPRT mice developed an obese phenotype in contrast to weight loss in the R6/2 and N171–82Q mice. These mice showed a small striatal NAA loss (21%), and a possible increase in brain lipids detectable by magnetic resonance (MR) spectroscopy and decreased brain water T1. Our results indicate profound metabolic defects that are strongly affected by CAG repeat length, as well as gene expression levels and protein context.Keywords
This publication has 40 references indexed in Scilit:
- Huntingtin Controls Neurotrophic Support and Survival of Neurons by Enhancing BDNF Vesicular Transport along MicrotubulesCell, 2004
- Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutaminesNature Neuroscience, 2002
- N-Acetylaspartate and DARPP-32 levels decrease in the corpus striatum of Huntingtonʼs disease miceNeuroReport, 2000
- CAG--polyglutamine repeat mutations: independence from gene contextPhilosophical Transactions Of The Royal Society B-Biological Sciences, 1999
- Exon 1 of the HD Gene with an Expanded CAG Repeat Is Sufficient to Cause a Progressive Neurological Phenotype in Transgenic MiceCell, 1996
- Relationship between trinucliotide repeats and neuropathological changes in Huntington's dieaseAnnals of Neurology, 1996
- Regulation of mammalian brain cell volumeJournal of Experimental Zoology, 1994
- Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington's diseaseNature Genetics, 1993
- A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomesCell, 1993
- Significance tests on the crystallographic R factorActa Crystallographica, 1965